alpha-synuclein oligomerization
alpha-synuclein aggregates
accumulation of oligomeric alpha-synuclein
features of GD
GD results
PD pathophysiology
impaired lysosomal function
PD molecular mechanisms
genetic PD forms
impaired cellular quality control - impaired autophagy
mitochondrial dysfunction
Gaucher’s disease
Parkinson’s disease
impaired clearance mechanisms
cellular quality control pathways
GD mouse model
defects
pathophysiological features of
GCase mutations
similar features
strong genetic association
lysosomal storage disorder
gba knockout mice
inducible pluripotent stem cells
characteristic proteins inclusions
main constituent of Lewy Bodies
key links
activity
severe neurodegeneration
primary neuronal cultures
children
attempt
patients
array of biochemical
advanced imaging techniques
parkinsonian brains
new therapeutic targets
specific interactions
enzyme glucocerebrosidase
insights
Recent studies
unifying hypothesis
fact
diverse findings
work
present study
models